TNF-α promotes fracture repair by augmenting the recruitment and differentiation of muscle-derived stromal cells

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 4, 2011, Pages 1585-1590

  Glass, Graeme E ^a,b   Chan, James K ^a,b   Freidin, Andrew ^a   Feldmann, Marc ^a   Horwood, Nicole J ^a   Nanchahal, Jagdeep ^a,b  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL MIGRATION; CONTROLLED STUDY; DRUG EFFECT; FRACTURE HEALING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MUSCLE CELL; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; STROMA CELL; TIBIA FRACTURE;

5'-NUCLEOTIDASE; ALKALINE PHOSPHATASE; ANIMALS; ANTIGENS, THY-1; CELL DIFFERENTIATION; CELL MOVEMENT; CELL PROLIFERATION; CELLS, CULTURED; CHEMOKINE CCL2; CHEMOKINE CXCL12; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; FRACTURE HEALING; FRACTURES, BONE; HUMANS; MICE; MICE, INBRED C57BL; MUSCLE CELLS; MUSCLE, SKELETAL; OSTEOGENESIS; PLATELET-DERIVED GROWTH FACTOR; STROMAL CELLS; TUMOR NECROSIS FACTOR-ALPHA;

MURINAE;

EID: 79952122953     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1018501108     Document Type: Article

References (48)

1. Bosse MJ, et al. (2002) An analysis of outcomes of reconstruction or amputation after leg-threatening injuries. N Engl J Med 347:1924-1931. (Pubitemid 35429922)
2. Castillo RC, MacKenzie EJ, Wegener ST, Bosse MJ; LEAP Study Group (2006) Prevalence of chronic pain seven years following limb threatening lower extremity trauma. Pain 124:321-329. (Pubitemid 44397250)
3. MacKenzie EJ, et al. (2006) Early predictors of long-term work disability after major limb trauma. J Trauma 61:688-694. (Pubitemid 44400956)
4. McCarthy ML, et al.; LEAP study group (2003) Psychological distress associated with severe lower-limb injury. J Bone Joint Surg Am 85-A:1689-1697.
5. Friedlaender GE, et al. (2001) Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A:(Pt 2, Suppl 1):S151-S158.
6. Govender S, et al.; BMP-2 Evaluation in Surgery for Tibial Trauma (BESTT) Study Group (2002) Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: A prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 84-A:2123-2134.
7. Lane JM (2001) BMPs: Why are they not in everyday use? J Bone Joint Surg Am 83-A (Pt 2, Suppl 1):S161-S163.
8. Lieberman JR, Daluiski A, Einhorn TA (2002) The role of growth factors in the repair of bone. Biology and clinical applications. J Bone Joint Surg Am 84-A:1032-1044.
9. Corsi KA, Schwarz EM, Mooney DJ, Huard J (2007) Regenerative medicine in orthopaedic surgery. J Orthop Res 25:1261-1268. (Pubitemid 47523355)
10. Dragoo JL, et al. (2003) Bone induction by BMP-2 transduced stem cells derived from human fat. J Orthop Res 21:622-629. (Pubitemid 36758206)
11. Baltzer AW, et al. (2000) Potential role of direct adenoviral gene transfer in enhancing fracture repair. Clin Orthop Relat Res 379:(379, Suppl):S120-S125.
12. Huang X, Yang Y (2009) Innate immune recognition of viruses and viral vectors. Hum Gene Ther 20:293-301.
13. Lee JY, et al. (2000) Clonal isolation of muscle-derived cells capable of enhancing muscle regeneration and bone healing. J Cell Biol 150:1085-1100.
14. Qu-Petersen Z, et al. (2002) Identification of a novel population of muscle stem cells in mice: Potential for muscle regeneration. J Cell Biol 157:851-864. (Pubitemid 34847822)
15. Zuk PA, et al. (2001) Multilineage cells from human adipose tissue: Implications for cell-based therapies. Tissue Eng 7:211-228. (Pubitemid 32295155)
16. Toma JG, et al. (2001) Isolation of multipotent adult stem cells from the dermis of mammalian skin. Nat Cell Biol 3:778-784. (Pubitemid 32842682)
17. Urist MR (1965) Bone: Formation by autoinduction. Science 150:893-899.
18. McKibbin B (1978) The biology of fracture healing in long bones. J Bone Joint Surg Br 60-B:150-162.
19. Einhorn TA (1998) The cell and molecular biology of fracture healing. Clin Orthop Relat Res 355:(355, Suppl):S7-S21.
20. Harry LE, et al. (2008) Comparison of the healing of open tibial fractures covered with either muscle or fasciocutaneous tissue in a murine model. J Orthop Res 26:1238-1244.
21. Harry LE, Sandison A, Pearse MF, Paleolog EM, Nanchahal J (2009) Comparison of the vascularity of fasciocutaneous tissue and muscle for coverage of open tibial fractures. Plast Reconstr Surg 124:1211-1219.
22. Dimitriou R, Tsiridis E, Giannoudis PV (2005) Current concepts of molecular aspects of bone healing. Injury 36:1392-1404. (Pubitemid 41618169)
23. Mountziaris PM, Mikos AG (2008) Modulation of the inflammatory response for enhanced bone tissue regeneration. Tissue Eng Part B Rev 14:179-186. (Pubitemid 351839215)
24. Cho TJ, Gerstenfeld LC, Einhorn TA (2002) Differential temporal expression of members of the transforming growth factor beta superfamily during murine fracture healing. J Bone Miner Res 17:513-520. (Pubitemid 34171766)
25. Kon T, et al. (2001) Expression of osteoprotegerin, receptor activator of NF-kappaB ligand (osteoprotegerin ligand) and related proinflammatory cytokines during fracture healing. J Bone Miner Res 16:1004-1014. (Pubitemid 32467144)
26. Lehmann W, et al. (2005) Tumor necrosis factor alpha (TNF-alpha) coordinately regulates the expression of specific matrix metalloproteinases (MMPS) and angiogenic factors during fracture healing. Bone 36:300-310. (Pubitemid 40283587)
27. Gerstenfeld LC, et al. (2003) Impaired fracture healing in the absence of TNF-alpha signaling: The role of TNF-alpha in endochondral cartilage resorption. J Bone Miner Res 18:1584-1592. (Pubitemid 37022916)
28. Heymann D, Rousselle AV (2000) gp130 Cytokine family and bone cells. Cytokine 12:1455-1468.
29. Yang X, et al. (2007) Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 41:928-936. (Pubitemid 350116738)
30. Yano S, et al. (2005) Functional expression of beta-chemokine receptors in osteoblasts: Role of regulated upon activation, normal T cell expressed and secreted (RANTES) in osteoblasts and regulation of its secretion by osteoblasts and osteoclasts. Endocrinology 146:2324-2335. (Pubitemid 40577520)
31. Jones S, Horwood N, Cope A, Dazzi F (2007) The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol 179:2824-2831.
32. Gerstenfeld LC, Cullinane DM, Barnes GL, Graves DT, Einhorn TA (2003) Fracture healing as a post-natal developmental process: Molecular, spatial, and temporal aspects of its regulation. J Cell Biochem 88:873-884. (Pubitemid 36337032)
33. Hollinger JO, Hart CE, Hirsch SN, Lynch S, Friedlaender GE (2008) Recombinant human platelet-derived growth factor: Biology and clinical applications. J Bone Joint Surg Am 90(Suppl 1):48-54. (Pubitemid 351329121)
34. Blades MC, et al. (2002) Stromal cell-derived factor 1 (CXCL12) induces monocyte migration into human synovium transplanted onto SCID Mice. Arthritis Rheum 46:824-836. (Pubitemid 34214266)
35. Ponte AL, et al. (2007) The in vitro migration capacity of human bone marrow mesenchymal stem cells: Comparison of chemokine and growth factor chemotactic activities. Stem Cells 25:1737-1745. (Pubitemid 47121852)
36. Stich S, et al. (2008) Human periosteum-derived progenitor cells express distinct chemokine receptors and migrate upon stimulation with CCL2, CCL25, CXCL8, CXCL12, and CXCL13. Eur J Cell Biol 87:365-376.
37. Harvey N, Dennison E, Cooper C (2010) Osteoporosis: Impact on health and economics. Nat Rev Rheumatol 6:99-105.
38. Fukui N, Zhu Y, Maloney WJ, Clohisy J, Sandell LJ (2003) Stimulation of BMP-2 expression by pro-inflammatory cytokines IL-1 and TNF-alpha in normal and osteoarthritic chondrocytes. J Bone Joint Surg Am 85A(Suppl 3):59-66.
39. Rifas L (2006) T-cell cytokine induction of BMP-2 regulates human mesenchymal stromal cell differentiation and mineralization. J Cell Biochem 98:706-714.
40. Yeh LC, Zavala MC, Lee JC (2002) Osteogenic protein-1 and interleukin-6 with its soluble receptor synergistically stimulate rat osteoblastic cell differentiation. J Cell Physiol 190:322-331. (Pubitemid 34111973)
41. Gilbert L, et al. (2000) Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141:3956-3964.
42. Gilbert LC, Rubin J, Nanes MS (2005) The p55 TNF receptor mediates TNF inhibition of osteoblast differentiation independently of apoptosis. Am J Physiol Endocrinol Metab 288:E1011-E1018. (Pubitemid 40547896)
43. Hashimoto J, et al. (1989) Inhibitory effects of tumor necrosis factor alpha on fracture healing in rats. Bone 10:453-457. (Pubitemid 20114927)
44. Yoshikawa H, Hashimoto J, Masuhara K, Takaoka K, Ono K (1988) Inhibition by tumor necrosis factor of induction of ectopic bone formation by osteosarcoma-derived bone-inducing substance. Bone 9:391-396. (Pubitemid 19096273)
45. Balga R, et al. (2006) Tumor necrosis factor-alpha: Alternative role as an inhibitor of osteoclast formation in vitro. Bone 39:325-335. (Pubitemid 43851380)
46. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP (1997) Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem 64:295-312. (Pubitemid 27065443)
47. Franchimont N, Wertz S, Malaise M (2005) Interleukin-6: An osteotropic factor influencing bone formation? Bone 37:601-606.
48. Kozawa O, Suzuki A, Kaida T, Tokuda H, Uematsu T (1997) Tumor necrosis factor-alpha autoregulates interleukin-6 synthesis via activation of protein kinase C. Function of sphingosine 1-phosphate and phosphatidylcholine-specific phospholipase C. J Biol Chem 272:25099-25104. (Pubitemid 27415692)